Detection of circulating tumor cells in peripheral blood of heavily treated metastatic breast cancer patients
スポンサーリンク
概要
- 論文の詳細を見る
- 2011-07-01
著者
-
TAIRA Shinichiro
Department of Fifth Surgery, Hachioji Medical Center, Tokyo Medical University
-
Shiba T
Department Of Medical Oncology The Cancer Institute Of Japanese Foundation For Cancer Research
-
Watanabe Chie
Department Of Molecular Immunology Research Institute For Microbial Diseases And Crest Program Of Js
-
Terui Shoji
国立がんセンター中央病院
-
Hatake Kiyohiko
Department Of Medical Oncology Cancer Institute Hospital Of Japanese Foundation For Cancer Research
-
TSUTSUMI Chizuko
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
Takahashi Shunji
Cancer Inst. Hospital Tokyo Jpn
-
Hatake Kiyohiko
Division Of Medical Oncology Cancer Institute Hospital
-
Hatake Kiyohiko
Department Of Hematology Jichi Medical School
-
TAKAYAMA Shin
Department of Surgery
-
INOUE Kenichi
Department of Breast Oncology, Saitama Cancer Center
-
Ito Yoshinori
Department Of Medical Oncology The Cancer Institute Of Japanese Foundation For Cancer Research
-
Shiba Tadayoshi
Department Of Molecular Biology Kitasato University
-
Hirata Kouichi
First Department Of Surgery Sapporo Medical College
-
Takahashi Shunji
Department Of Oncology And Hematology Cancer Institute Hospital
-
Takahashi Shunji
Department Of Anesthesiology Nagasaki University School Of Medicine
-
Hatake Kiyohiko
Olympus Bio-imaging Laboratory The Cancer Chemotherapy Center Of The Jfcr
-
Hatake Kiyohiko
Department Of Medical Oncology Ariake Cancer Institute Hospital
-
Tokudome Nahomi
Department Of Medical Oncology The Cancer Institute Of Japanese Foundation For Cancer Research
-
Tsukahara Satomi
Department Of Medical Oncology Cancer Institute Hospital Japanese Foundation For Cancer Research
-
Tsukahara Satomi
Department Of Medical Oncology The Cancer Institute Of Japanese Foundation For Cancer Research
-
Ito Yoshinori
Department Of Biomedical Food Research National Institute Of Infectious Diseasea(former National Ins
-
Tokudome Nahomi
Department Of Medical Oncology Cancer Institute Hospital Japanese Foundation For Cancer Research
-
Ito Yoshinori
Departments Of Pathology Medical Oncology And Breast Oncology The Cancer Institute Hospital Of The J
-
Oba Masaru
Department Of Medical Oncology The Cancer Institute Hospital Of Japanese Foundation For Cancer Resea
-
KOBAYASHI Kokoro
Department of Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Rese
-
OTO Masafumi
Department of Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Rese
-
KUWAYAMA Akiko
Department of Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Rese
-
MASUMURA Kyoko
Department of Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Rese
-
NAKAYAMA Yoshie
Department of Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Rese
-
Oto Masafumi
Department Of Medical Oncology The Cancer Institute Hospital Of Japanese Foundation For Cancer Resea
-
Masumura Kyoko
Department Of Medical Oncology The Cancer Institute Hospital Of Japanese Foundation For Cancer Resea
-
Kuwayama Akiko
Department Of Medical Oncology The Cancer Institute Hospital Of Japanese Foundation For Cancer Resea
-
Nakayama Yoshie
Department Of Medical Oncology The Cancer Institute Hospital Of Japanese Foundation For Cancer Resea
-
Kobayashi Kokoro
Department Of Medical Oncology The Cancer Institute Hospital Of Japanese Foundation For Cancer Resea
-
Inoue Kenichi
Department Of Medical Oncology The Cancer Institute Hospital Of Japanese Foundation For Cancer Resea
-
Tsutsumi Chizuko
Department Of Medical Oncology The Cancer Institute Hospital Of Japanese Foundation For Cancer Resea
-
Ito Yoshinori
Department Of Biochemistry Nagoya City University Medical School
-
Taira Shinichiro
Department Of Medical Oncology The Cancer Institute Hospital Of Japanese Foundation For Cancer Resea
-
Watanabe Chie
Department Of Medical Oncology Cancer Institute Hospital Japanese Foundation For Cancer Research
-
Ito Yoshinori
Department Of Breast Oncology The Cancer Institute Hospital Of The Japanese Foundation For Cancer Research
-
TSUTSUMI Chizuko
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute Nagasaki University Graduate School of Biosciences
関連論文
- Cancer of Unknown Primary Site:A Review of 28 Cases and the Efficacy of Cisplatin/Docetaxel Therapy at a Single Institute in Japan
- Evidence of Different Pharmacokinetics Including Relationship among AUC, Peak, and Trough Levels between Cyclosporine and Tacrolimus in Renal Transplant Recipients Using New Pharmacokinetic Parameter : Why Cyclosporine Is Monitored by C_2 Level and Tacrol
- Evidence of Different Pharmacokinetics Including Relationship among AUC, Peak, and Trough Levels between Cyclosporine and Tacrolimus in Renal Transplant Recipients Using New Pharmacokinetic Parameter : Why Cyclosporine Is Monitored by C_2 Level and Tacrol
- Evidence of Different Pharmacokinetics Including Relationship among AUC, Peak, and Trough Levels between Cyclosporine and Tacrolimus in Renal Transplant Recipients Using New Pharmacokinetic Parameter : Why Cyclosporine Is Monitored by C_2 Level and Tacrol
- Evidence of Different Pharmacokinetics Including Relationship among AUC, Peak, and Trough Levels between Cyclosporine and Tacrolimus in Renal Transplant Recipients Using New Pharmacokinetic Parameter : Why Cyclosporine Is Monitored by C_2 Level and Tacrol
- Cross-sectional analysis of germline BRCA1 and BRCA2 mutations in Japanese patients suspected to have hereditary breast/ovarian cancer
- Inhibitory Mechanisms of Glycoprotein Fraction Derived from Miscanthus sinensis for the Immediate Phase Response of an IgE-Mediated Cutaneous Reaction
- Primary Hepatic Low-Grade B-Cell Lymphoma of the Mucosa-Associated Lymphoid Tissue Type : A Case Report and Review of the Literature
- No beneficial effect from addition of etoposide to daunorubicin,cytarabine,and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia:the JALSG-AML92 study
- Imatinib Provides Durable Molecular and Cytogenetic Responses in a Practical Setting for Both Newly Diagnosed and Previously Treated Chronic Myelogenous Leukemia : A Study in Nagasaki Prefecture, Japan
- Histological Features of Breast Cancer, Highly Sensitive to Chemotherapy
- Negative inotropic action of propofol is enhanced in the acute ischemic myocardium of dogs
- Successful Treatment With a Chimeric Anti-CD20 Monoclonal Antibody (IDEC-C2B8, Rituximab) for a Patient With Relapsed Mantle Cell Lymphoma Who Developed a Human Anti-Chimeric Antibody
- Successful Treatment of Multiple Myeloma-Associated Amyloidosis by Interferon-α, Dimethyl Sulfoxide, and VAD(Vincristine, Adriamycin, and Dexamethasone)
- Phenotypic Conversion of T-Lineage Lymphoblasts in the Lymph Node to Myeloblasts in the Bone Marrow During Relapse After Allogeneic Bone Marrow Transplantation
- Increased incidence of interstitial pneumonia by CHOP combined with rituximab
- A Case of Acute Promyelocytic Leukemia during Gefitinib Treatment
- Functional MRI : Principles and Applications to the Visual System
- Allelic Loss at 1p34,13q12,17p13.3,and 17q21.1 Correlates With Poor Postoperative Prognosis in Breast Cancer
- Correlation of Allelic Loss with Poor Postoperative Survival in Breast Cancer
- PTEN/MMAC1 Mutations in Hepatocellular Carcinomas: Somatic Inactivation of Both Alleles in Tumors
- Efficacy of S-1 in heavily pretreated patients with metastatic breast cancer : cross-resistance to capecitabine
- Pilot study of MDR1 gene transfer into hematopoietic stem cells and chemoprotection in metastatic breast cancer patients
- Does Lapatinib, a Small-Molecule Tyrosine Kinase Inhibitor, Constitute a Breakthrough in the Treatment of Breast Cancer?
- Efficacy and Safety of Combined Trastuzumab and Paclitaxel Therapy as a Second-Line Treatment in Women with Metastatic Breast Cancer : A Single Institutional Experience
- High Prevalence of HER-2/neu and p53 Overexpression in Inflammatory Breast Cancer
- Severe Infusion Reaction Induced by Trastuzumab : A Case Report
- Dose-finding phase I study of simultaneous weekly infusion with doxorubicin and docetaxel in patients with advanced breast cancer
- Pilot study of continuous low-dose 5-fluorouracil and cisplatin (FP regimen) for the treatment of metastatic breast cancer
- Expression profiling to predict postoperative prognosis for estrogen receptor-negative breast cancers by analysis of 25,344 genes on a cDNA microarray
- Amplification, up-regulation and over-expression of DVL-1, the human counterpart of the Drosophila disheveled gene, in primary breast cancers
- Nucleotide variations in genes encoding plasminogen activator inhibitor-2 and serine proteinase inhibitor B10 associated with prostate cancer
- Association of common missense changes in ELAC2 (HPC2) with prostate cancer in a Japanese case-control series
- High proportion of missense mutations of the BRCA1 and BRCA2 genes in Japanese breast cancer families
- Assessment of hormone receptor status in breast cancer
- Circulating tumor cells as a surrogate marker for determining response to chemotherapy in patients with advanced gastric cancer
- Next Generation Molecular Targeted Agents for Breast Cancer : Focus on EGFR and VEGFR Pathways
- Chemotherapy for Small-Bowel Adenocarcinoma at a Single Institution
- Autophagy and autophagic cell death are next targets for elimination of the resistance to tyrosine kinase inhibitors
- Modified irinotecan plus bolus 5-fluorouracil/L-leucovorin for metastatic colorectal cancer at a single institution in Japan
- Continuous treatment of bestatin induces anti-angiogenic property in endothelial cells
- Differential Regulation of Eotaxin-1/CCL11 and Eotaxin-3/CCL26 Production by the TNF-α and IL-4 Stimulated Human Lung Fibroblast(Pharmacology)
- Blockade of bulky lymphoma-associated CD55 expression by RNA interference overcomes resistance to complement-dependent cytotoxicity with rituximab
- Gene Therapy for Breast Cancer.-Review of Clinical Gene Therapy Trials for Breast Cancer and MDR1 Gene Therapy Trial in Cancer Institute Hospital
- No CD117 expression on B progenitors in the regenerating bone marrow
- Rare but important adverse effects of all-trans retinoic acid in acute promyelocytic leukemia and their management
- Philadelphia chromosome-negative cells with trisomy 8 after busulfan and interferon treatment of Ph^1-positive chronic myelogenous leukemia
- A survey of the timing and approach to the surgical management of patients with acute cholecystitis in Japanese hospitals
- Sentinel Lymph Node Biopsy Using Tin Colloid RI and Blue Dye Method
- Requirement for CD100-CD72 interactions in fine-tuning of B-cell antigen receptor signaling and homeostatic maintenance of the B-cell compartment
- A third-phase cutaneous (very late phase) response after elicitation with dinitrofluorobenzene in passively or actively sensitized mice
- Combination Docetaxel and Trastuzumab Treatment for Patients with HER-2-Overexpressing Metastatic Breast Cancer : A Multicenter, Phase-II Study
- Tolerability and Safety of Classic Cyclophosphamide, Methotrexate, and Fluorouracil Treatment in Japanese Patients with Early Breast Cancer
- Reviewing the definition of "elderly"
- Report from the second Japanese Urological Association-Japanese Society of Medical Oncology joint conference, 2007 : 'Diagnosis and treatment of urological malignant tumors : How can we promote subspecialists?'
- Association of single nucleotide polymorphisms in the promoter region of the pro-opiomelanocortin gene (POMC) with low bone mineral density in adult women
- Association of a single-nucleotide polymorphism in the promoter region of leukemia inhibitory factor receptor gene with low bone mineral density in adult women
- Association of genetic variation of the RIL gene, encoding a PDZ-LIM domain protein and localized in 5q31.1, with low bone mineral density in adult Japanese women
- Association of natural tooth loss with genetic variation at the human matrix Gla protein locus in elderly women
- Association of the -381T/C promoter variation of the brain natriuretic peptide gene with low bone-mineral density and rapid postmenopausal bone loss
- Thirteen single-nucleotide polymorphisms in the human osteopontin gene identified by sequencing of the entire gene in Japanese individuals
- Linkage disequilibrium and haplotype analysis among ten single-nucleotide polymorphisms of interleukin 11 identified by sequencing of the gene
- A nucleotide variant in the promoter region of the interleukin-6 gene associated with decreased bone mineral density
- Linkage of interleukin 6 locus to human osteopenia by sibling pair analysis
- Association of bone mineral density with polymorphism of the human matrix Gla protein locus in elderly women
- Trends in the incidence of hip fracture in Japan,1987-1997:The third nationwide survey
- Stanniocalcin 2 overexpression in castration-resistant prostate cancer and aggressive prostate cancer
- Oncogenic role of NALP7 in testicular seminomas
- Prospective study of combined treatment with interferon-alpha and active vitamin D_3 for Japanese patients with metastatic renal cell carcinoma
- Novel single nucleotide polymorphisms of the human nuclear factor kappa-B 2 gene identified by sequencing the entire gene
- Lipomatous Hypertrophy of the Interatrial Septum With Cutaneous Lipomatosis
- Establishment and Characterization of GSA-1, a Human Cell Line Highly Susceptible to Apoptosis after Free-fall
- Purification and Characterization of Ferredoxin-Sulfite Reductase from Turnip (Brassica rapa) Leaves and Comparison of Properties with Ferredoxin-Sulfite Reductase from Turnip Roots
- Functional in vivo optical imaging of tumor angiogenesis, growth, and metastasis prevented by administration of anti-human VEGF antibody in xenograft model of human fibrosarcoma HT1080 cells
- Overexpression of the potential kinase serine/threonine/tyrosine kinase 1 (STYK 1) in castration-resistant prostate cancer
- Possible use of combination chemotherapy with mitomycin C and methotrexate for metastatic breast cancer pretreated with anthracycline and taxanes
- Association of radial bone mineral density with CA repeat polymorphism at the interleukin 6 locus in postmenoposal Japanese women
- Complete Resection After Imatinib Treatment of a Gastrointestinal Stromal Tumor of the Ileum with Peritoneal Metastases : Report of a Case
- Estrone and 17β-Estradiol Reverse Breast Cancer Resistance Protein-mediated Multidrug Resistance
- Identification and Characterization of a Deletion Mutant of DNA Topoisomerase I mRNA in a Camptothecin-resistant Subline of Human Colon Carcinoma
- Augmentation of Cancer Chemotherapy by Preinjection of Human Macrophage Colony-stimulating Factor in L1210 Leukemic Cell-inoculated Mice
- Recent advances in ideas on the molecular pathology and clinical aspects of Von Hippel-Lindau disease
- Apocrine metaplasia of breast cancer : clinicopathological features and predicting response
- Phase I study of inotuzumab ozogamicin (CMC-544) in Japanese patients with follicular lymphoma pretreated with rituximab-based therapy
- Dlk-1, a cell surface antigen on foetal hepatic stem/progenitor cells, is expressed in hepatocellular, colon, pancreas and breast carcinomas at a high frequency
- Reoperative Sentinel Lymph Node Biopsy for Ipsilateral Breast Tumor Recurrence After Previous Axillary Lymph Node Dissection : Report of a Case
- 5αDH-DOC (5α-dihydro-deoxycorticosterone) activates androgen receptor in castration-resistant prostate cancer
- Clinical efficacy and safety of biapenem for febrile neutropenia in patients with underlying hematopoietic diseases : a multi-institutional study
- Anal Canal Carcinoma with Pagetoid Spread : Report of a Case
- Estrogen-mediated post transcriptional down-regulation of P-glycoprotein in MDR1-transduced human breast cancer cells
- Circulating tumor cells as a surrogate marker for determining response to chemotherapy in Japanese patients with metastatic colorectal cancer
- Prospective randomized phase II study determines the clinical usefulness of genetic biomarkers for sensitivity to primary chemotherapy with paclitaxel in breast cancer
- Predictors of the Efficacy of FOLFIRI plus Bevacizumab as Second-Line Treatment in Metastatic Colorectal Cancer Patients
- Detection of circulating tumor cells in peripheral blood of heavily treated metastatic breast cancer patients
- Incidence of chemotherapy-induced amenorrhea in premenopausal patients with breast cancer following adjuvant anthracycline and taxane
- Phase I study of dasatinib (BMS-354825) in Japanese patients with solid tumors
- Biomarkers to predict response to sunitinib therapy and prognosis in metastatic renal cell cancer
- 5. Tanstuzumab Treatment for Breast Cancer
- A lower dose of docetaxel at 60mg/m^2 could be continued longer for controlling peripheral edema in patients with metastatic breast cancer
- Eradication of breast cancer cells in patients with distant metastasis : the finishing touches?